Small Business Innovation Research Phase IIB Bridge Awards
by:
TopGovernmentGrants Editorial StaffThe National Institutes of Health, otherwise known as NIH, is an agency that is operating within the Department of Health and Human Services.
The National Institutes of Health is the United States government's principal agency that is responsible for most of the country's biomedical and health-related research studies.
The mission of the NIH is to continuously obtain new information that would help prevent, detect, diagnose, and treat diseases and disabilities.
In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.
The program is in conjunction with the long running Small Business Innovation Research (SBIR) Program of NIH. The purpose of the SBIR program is to facilitate the innovation of solutions to existing health challenges by aiding the commercialization of the technologies that have been developed by small business concerns.
(continued...)
Small Business Innovation Research Phase IIB Bridge Awards
Page 2
About The Author
The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs.
The staff also provides resources to other Websites with information on environmental grants and grants for youth programs.
|
Additional Resources
category - Health Grants
Medical Tropical Research Laboratory Program Infectious Disease Research AwardAFRIMS has recently announced the WRAIR Medical Tropical Research Laboratory Program(MTRLP) Infectious Disease Research Award(IDRA), a funding opportunity which solicits proposals that aim to tackle basic, preclinical and clinical research of emerging infectious diseases in Thailand and a certain region in Southeast Asia.
National Institutes of Health funds the Improving Adherence to Treatment Regimens for HIV-Positive Adolescents and Young Adults The National Institutes of Health has recently established a program entitled Improving Adherence to Treatment Regimens for HIV-Positive Adolescents and Young Adults wherein they intend to kick-off research studies that will create, implement, and evaluate both old and new interventions that are geared towards improving adherence to medical and behavioral regimens for HIV-positive adolescents which are 11 to 21 years old and adults who are 21 to 24 years old.
Strategic Alliances for Medications Development to Treat Substance Use Disorder ProgramThe National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.
2012 Tuberous Sclerosis Complex Clinical Trial Award ProgramIn line with this mission, the United States Department of Defense has recently established the 2012 Tuberous Sclerosis Complex Clinical Trial Award Program in an attempt to financially support the studies regarding the promotion innovative research focused on decreasing the clinical impact of tuberous sclerosis complex (TSC).